Illumina discloses terms of settlement with Chinese rival BGI Genomics
MLex Summary: US biotech company Illumina has disclosed in a US regulatory filing the terms of a July 14 settlement of antitrust and intellectual property disputes with Chinese competitor BGI Genomics....To view the full article, register now.
Already a subscriber? Click here to view full article